How the lack of clear, concise data has impacted opioid prescribing for chronic pain and is clouding the issue of medical recertification
Search results for: tramadol
Decernotinib, Subcutaneous Methotrexate Drug Updates, Trials, Approvals
Plus, rheumatology drug news, safety updates
How to Manage Pain in Patients with Renal Insufficiency or End-Stage Renal Disease on Dialysis
Narcotic and non-narcotic pain regimens can be used
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Coding Corner Question: February
Test your coding knowledge for an office visit for a 51-year-old female patient with osteoarthritis in her right knee who returns for a follow-up with the physician assistant six weeks after she received an intraarticular corticosteroid injection in her knee
ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
Coding Corner: Real-Life Rheumatology Note
A 46-year-old white female comes in for consultation on her arthritis pain.
New Osteoarthritis Recommendations and Classification Criteria for Sjögren’s Syndrome and Polymyalgia Rheumatica
The ACR has published three documents intended to provide clarity and consensus on management of osteoarthritis, classification criteria for Sjögren’s syndrome, and classification criteria for polymyalgia rheumatica. The documents, which represent the most current clinical evidence, research, and expert panel input and review, can help inform clinical practice and provide clearer target populations for future research.
The Role of the Physician Assistant in the Treatment of Pain
Pain is a common manifestation of rheumatic conditions. Patients with rheumatic diseases such as rheumatoid arthritis, lupus, gout, and osteoarthritis require disease-specific management for controlling acute episodes of pain as well as strategies to control ongoing daily discomfort.
High Cost, No Benefit
Why are so many brand-name drugs approved after generic versions become available?